BiotechTube
Home/AC Immune/Prof. Andrea Pfeifer
PA

Prof. Andrea Pfeifer

Co-Founder, Chief Executive Officer and Director

AC Immune

Therapeutic Areas

Alzheimer's DiseaseParkinson's DiseaseNeurodegenerative DiseasesTauopathiesSynucleinopathiesTDP-43 Proteinopathies

AC Immune Pipeline

DrugIndicationPhase
ACI-7104.056Parkinson's DiseasePhase 2
Anti-Abeta Active ImmunotherapyAlzheimer's DiseasePhase 2 (Prevention)
Anti-pTau Active ImmunotherapyAlzheimer's Disease (Preclinical)Phase 2 (Prevention)
SemorinemabAlzheimer's DiseasePhase 2
ACI-3024Alzheimer's Disease / TauopathiesPhase 1
ACI-19626 (TDP-43 PET Tracer)TDP-43 ProteinopathiesPreclinical
Alpha-synuclein PET TracerParkinson's DiseasePhase 1
PI-2620 (Tau PET Tracer)Alzheimer's Disease, PSPCommercial

Leadership Team at AC Immune

CR
Christopher Roberts
Chief Financial Officer
PD
Piergiorgio Donati
Chief Technical Operations Officer
MD
Mark Danton
EVP, Artificial Intelligence
CM
Catherine Mummery, MD
Chair of Clinical Advisory Board
View full AC Immune profile